Prevention of Infection in Critically Ill Patients by Selective Decontamination of the Digestive Tract

OBJECTIVE To determine whether selective decontamination of the digestive tract using oral and nonabsorbable antimicrobial agents and parenteral cefotaxime prevents infection in critically ill patients. DESIGN Randomized, controlled trial without blinding. SETTING Surgical trauma and medical intensive care units in a tertiary referral hospital. PATIENTS One hundred fifty patients admitted to surgical trauma and medical intensive care units during a 3-year interval, whose condition suggested a prolonged stay (greater than 3 days). INTERVENTION Patients were randomly allocated to an experimental group (n = 75) that received cefotaxime, 1 g intravenously every 8 hours for the first 3 days only, and oral, nonabsorbable antibiotics (gentamicin, polymyxin, and nystatin by oral paste and oral liquid) for the entire stay in the intensive care unit. Control patients (n = 75) received usual care. MEASUREMENTS The number of infections, total hospital days, and deaths, as well as the number of days in intensive care unit, were recorded. RESULTS Control patients experienced more infections (36 compared with 12, P = 0.04), including bacteremias (14 compared with 4, P = 0.05) and pulmonary infections (14 compared with 4, P = 0.03). Although total hospital days, days in intensive care, and the overall death rate all were lower in the treatment group, these differences were not statistically significant. Clinically important complications of selective decontamination of the digestive tract were not encountered. CONCLUSIONS Selective decontamination of the digestive tract decreases subsequent infection rates, especially by gram-negative bacilli, in selected patients during long-term stays in the intensive care unit.

[1]  S. Chevret,et al.  A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract. , 1992, The New England journal of medicine.

[2]  J. Vandenbroucke,et al.  Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit , 1991, The Lancet.

[3]  D. Craven,et al.  Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s. , 1991, The American journal of medicine.

[4]  C. Stoutenbeek,et al.  Selective decontamination of the digestive tract (SDD) in intensive care patients: a critical evaluation of the clinical, bacteriological and epidemiological benefits. , 1991, The Journal of hospital infection.

[5]  R. Auckenthaler,et al.  Oropharyngeal Decontamination Decreases Incidence of Ventilator-Associated Pneumonia: A Randomized, Placebo-Controlled, Double-blind Clinical Trial , 1991 .

[6]  W. Fegeler,et al.  Effect of selective flora suppression on colonization, infection, and mortality in critically ill patients: A one‐year, prospective consecutive study , 1991, Critical care medicine.

[7]  D. Hoyt,et al.  Immunosuppression in Trauma Patients , 1991 .

[8]  R. Weinstein,et al.  Pilot trial of selective decontamination for prevention of bacterial infection in an intensive care unit. , 1990, The Journal of infectious diseases.

[9]  G. Ramsay,et al.  Clinical trials of selective decontamination of the digestive tract: Review , 1990, Critical care medicine.

[10]  A. Carrillo,et al.  Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial pharyngeal nonabsorbable paste. , 1990, Critical care medicine.

[11]  P. Mcclelland,et al.  Reducing sepsis in severe combined acute renal and respiratory failure by selective decontamination of the digestive tract. , 1990, Critical care medicine.

[12]  R. Weinstein,et al.  Infection control and pneumonia prophylaxis strategies in the intensive care unit. , 1990, Seminars in respiratory infections.

[13]  D. Craven,et al.  Nosocomial pneumonia in the intubated patient. New concepts on pathogenesis and prevention. , 1989, Infectious disease clinics of North America.

[14]  F Lemaire,et al.  Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. , 1989, Annals of internal medicine.

[15]  F. Daschner.  Cost-effectiveness in hospital infection control--lessons for the 1990s. , 1989, The Journal of hospital infection.

[16]  B. Farr,et al.  Economic benefits of an effective infection control program: case study and proposal. , 1989, Reviews of infectious diseases.

[17]  J. Verhoef,et al.  Prevention of colonization and infection in critically ill patients: a prospective randomized study. , 1988, Critical care medicine.

[18]  T. Louie,et al.  Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. , 1988, The American journal of medicine.

[19]  G. Ramsay,et al.  TRIPLE REGIMEN OF SELECTIVE DECONTAMINATION OF THE DIGESTIVE TRACT, SYSTEMIC CEFOTAXIME, AND MICROBIOLOGICAL SURVEILLANCE FOR PREVENTION OF ACQUIRED INFECTION IN INTENSIVE CARE , 1988, The Lancet.

[20]  Palmer Lb.  Bacterial colonization: pathogenesis and clinical significance. , 1987 .

[21]  M. Jackson,et al.  Rethinking the role of isolation practices in the prevention of nosocomial infections. , 1987, Annals of internal medicine.

[22]  D. Zandstra,et al.  The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit. , 1987, The Journal of antimicrobial chemotherapy.

[23]  D. Zandstra,et al.  The effect of oropharyngeal decontamination using topical nonabsorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients. , 1987, The Journal of trauma.

[24]  J. A. Kruse,et al.  Nosocomial infection among patients in different types of intensive care units at a city hospital , 1986, Critical care medicine.

[25]  W. Knaus,et al.  An evaluation of outcome from intensive care in major medical centers. , 1986, Annals of internal medicine.

[26]  E. Draper,et al.  Prognosis in Acute Organ‐System Failure , 1985, Annals of surgery.

[27]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[28]  P. Gross,et al.  Nosocomial infections and hospital deaths. A case-control study. , 1983, The American journal of medicine.

[29]  D. Zandstra,et al.  Environment and costs in surgical intensive care unit. The implication of selective decontamination of the digestive tract (SDD). , 1983, Acta anaesthesiologica Belgica.

[30]  P. Mackowiak.  The normal microbial flora. , 1982, The New England journal of medicine.

[31]  J. Washington,et al.  Laboratory Procedures in Clinical Microbiology , 1982, Springer US.

[32]  J. M. Wilson,et al.  Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia. , 1982, The New England journal of medicine.

[33]  H. Champion,et al.  Assessment of injury severity: the Triage Index , 1980, Critical care medicine.

[34]  D. Zandstra,et al.  Cefotaxime Combined with Selective Decontamination in Long-term Intensive Care Unit Patients: Virtual Absence of Emergence of Resistance , 1988 .

[35]  R. Haley,et al.  Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. , 1981, The American journal of medicine.